Over 25 years ago, modern restorative neurosurgery began with the concept of the possibility of replacing human neurons to treat neurodegenerative diseases. Recently, researchers have found reason to believe that the final goal of reconstructing neuronal pathways may one day be achieved. If so, this new technology may lead to the replacement, release, and regeneration of tissues damaged by a wide variety neurodegenerative diseases.
Transplantation of human neuronal cells is rapidly arising as a promising approach for ameliorating functional deficits caused by central nervous system disease or injury. Among current projects, Institute researchers are studying the safety and feasibility of human neuronal cellular transplantation in patients with basal ganglia stroke and fixed motor deficits. However, in the near future, the second phase of the neural transplantation project will begin to explore potential treatments to restore lost function from central nervous (CNS) disorders, including Parkinson's disease, Huntington's disease and spinal cord injury.
Read more…
Engineering neural progenitor cells for the treatment of central nervous system disorders